Page last updated: 2024-11-04

terbutaline and Malignant Melanoma

terbutaline has been researched along with Malignant Melanoma in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Research Excerpts

ExcerptRelevanceReference
"3 mM) moderately increased the tyrosinase activity of cultured human melanoma cells, while another beta-adrenoceptor agonist, terbutaline (1-3 mM) and a catechol compound, dopac (0."3.67Stimulation of tyrosinase by dihydroxy phenyl derivatives. ( Karg, E; Rorsman, H; Rosengren, E, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karg, E1
Rosengren, E1
Rorsman, H1

Other Studies

1 other study available for terbutaline and Malignant Melanoma

ArticleYear
Stimulation of tyrosinase by dihydroxy phenyl derivatives.
    Acta dermato-venereologica, 1989, Volume: 69, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Catechol Oxidase; Cell Line; Enzyme Activation; Humans; Isoprotereno

1989